baiocchi marta

Dottoressa di ricerca

ciclo: XXXIII


relatore: Prof F. Cutruzzolà
co-supervisore: Prof F. Cutruzzolà

Titolo della tesi: A colorectal cancer stem cells (CSCs) biobank as a multi-level approach to drug sensitivity studies.

Abstract Cancer stem cells (CSCs), recently identified in the majority of solid tumors, are a subpopulation of slow-replicating cells that drive tumor growth, by generating a cascade of differentiated cells that actually constitutes the bulk of the tumor. CSCs are selectively resistant to antiproliferative and cytotoxic drugs; therefore, it is widely accepted that they represent one main determinant of tumor relapses following chemotherapy. Colorectal CSCs can be isolated from patient’s tumors, and grown in vitro in selective mediums in an undifferentiated state as spheroids. Upon injection into immunocompromised mice, they generate tumor xenografts that closely replicate the original parental tumor, in terms of both antigen expression and histological tissue organization. In the host institution, we have recently established a biobank of frozen colorectal CSCs derived from individual patient’s tumors [1]. Newly established cultures are routinely validated by i) patient-matching verification through STR (Short Tandem Repeats) analysis, ii) assessment of CSC capability to originate phenocopies of the original patient’s tumor upon xenografting into NSG mice, iii) analysis of expression of stem cell markers. CSCs are then molecularly characterized by whole exome sequencing (WES) and banked for future uses. This platform is a powerful tool for the screening of targeted therapies and for drug resistance molecular studies. During the last few years, it has allowed our group to assess and characterize the activity on colorectal CSCs of different antineoplastic agents, including CHK1-targeted therapy [2], novel NHERF1 inhibitors [3], and new chemical derivatives of fenretinide [4, 5]. In addition, it has allowed us to characterize the EMT-related transcription factor ZEB2 in CSCs quiescence and drug resistance [6]. Here in particular I report the results of a study on differential sensitivity to the anti-EGFR MoAb cetuximab, on different classes of Microsatellite Instable (MSI) versus Microsatellite Stable (MSS) colorectal cancer stem cells. MSI tumors represent a distinct group of colorectal cancers, characterized by deficiency in the mismatch repair machinery and by high mutation rate. By analyzing the effect of anti-EGFR MoAb cetuximab on a panel of cCSCs we observed that MSI strains display an increased resistance to anti-EGFR therapy as compared to MSS, irrespective of KRAS mutational status. Gene mutation analysis on MSI versus MSS CSCs revealed that MSI strains carry recurrent mutations within groups of genes coding for proteins with a role in RAS and calcium signaling, highlighting the role of a genomically unstable context in determining anti-EGFR resistance. Altogether, these results indicate a multifactorial origin of anti-EGFR resistance, which emerges as the effect of multiple events further than the KRAS mutation, targeting direct and indirect regulators of the EGFR pathway. Data have been published in [7]. References 1. De Angelis, M.L., et al., Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance. Stem Cells Transl Med, 2016. 5(4): p. 511-23. 2. Manic, G., et al., CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells. Gut, 2018. 67(5): p. 903-917. 3. Coluccia, A., et al., Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents. ACS Med Chem Lett, 2019. 10(4): p. 499-503. 4. Orienti, I., et al., A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors. Cell Death Dis, 2019. 10(7): p. 529. 5. Orienti, I., et al., A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells. J Exp Clin Cancer Res, 2019. 38(1): p. 373. 6. Francescangeli, F., et al., A pre-existing population of ZEB2(+) quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer. J Exp Clin Cancer Res, 2020. 39(1): p. 2. 7. De Angelis, M.L., et al., Colorectal cancer spheroid biobanks: multi-level approaches to drug sensitivity studies. Cell Biol Toxicol, 2018. 34(6): p. 459-469.

Produzione scientifica

  • 11573/1213098 - 1991 - Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface (01a Articolo in rivista)
    NICOLIS, SARA; OTTOLENGHI, SILVIA
  • 11573/1213106 - 2015 - Dynamic regulation of the cancer stem cell compartment by cripto-1 in colorectal cancer (01a Articolo in rivista)
    FRANCESCANGELI, FEDERICA; GAMBARA, GUIDO; PAGLIUCA, ALESSANDRA; TODARO, MATTIA
  • 11573/1213103 - 1997 - Human immunodeficiency virus (HIV)-resistant CD4+ UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection (01a Articolo in rivista)
  • 11573/1212499 - 2018 - Colorectal cancer spheroid biobanks: multi-level approaches to drug sensitivity studies (01a Articolo in rivista)
    FRANCESCANGELI, FEDERICA
  • 11573/1212760 - 1996 - Isolation and biological characterization of two classes of blast-cell colony-forming cells from normal murine marrow (01a Articolo in rivista)
  • 11573/751819 - 2012 - Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells (01a Articolo in rivista)
  • 11573/41273 - 2010 - New models for cancer research: human cancer stem cell xenografts (01a Articolo in rivista)
    PILOZZI, EMANUELA
  • 11573/869457 - 2016 - Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance (01a Articolo in rivista)
    PILOZZI, EMANUELA; FRANCESCANGELI, FEDERICA
  • 11573/739194 - 2014 - Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XLinhibition in non-small cell lung cancer (01a Articolo in rivista)
    FRANCESCANGELI, FEDERICA; APUZZO, TIZIANA
  • 11573/1027697 - 2017 - A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer (01a Articolo in rivista)
    CANZONIERI, VINCENZO; GIANNINI, GIUSEPPE
  • 11573/80932 - 2002 - The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues (01a Articolo in rivista)
    RIMINUCCI, MARA; DE ANGELIS, LUCIANA; BIANCO, PAOLO
  • 11573/396169 - 2009 - A powerful readout system for high resolution and high efficiency molecular imaging studies of cardiovascular diseases in mice (04b Atto di convegno in volume)
    DE VINCENTIS, GIUSEPPE
  • 11573/130893 - 2008 - Isolation and characterization of CD146+ multipotent mesenchymal stromal cells (01a Articolo in rivista)
    FATICA, ALESSANDRO
  • 11573/1223718 - 2019 - Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents (01a Articolo in rivista)
    COLUCCIA, ANTONIO; LA REGINA, GIUSEPPE; NACCARATO, VALENTINA; NALLI, MARIANNA; ORLANDO, VIVIANA; BIAGIONI, STEFANO; GAUTIER, CANDICE NATACHA ANNA; GIANNI, STEFANO; DI PASTENA, FIORELLA; DI MAGNO, LAURA; CANETTIERI, GIANLUCA; SILVESTRI, ROMANO
  • 11573/1221419 - 2003 - 5-azacytidine reactivates the erythroid differentiation potential of the myeloid-restricted murine cell line 32D Ro (01a Articolo in rivista)
  • 11573/1215209 - 2014 - Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines (01a Articolo in rivista)
  • 11573/1221428 - 1999 - Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis (01a Articolo in rivista)
  • 11573/1221430 - 2000 - An IL-6/IL-6 soluble receptor (IL-6R) hybrid protein (H-IL-6) induces EPO-independent erythroid differentiation in human CD34+cells (01a Articolo in rivista)
  • 11573/1221739 - 1993 - Aspects of the biology of the neonatal hematopoietic stem cell (01a Articolo in rivista)
  • 11573/1221831 - 2004 - Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34 +KDR+ cells (01a Articolo in rivista)
    CONDORELLI, GIANLUIGI
  • 11573/1221722 - 1996 - Circulating progenitor cells in human ontogenesis: response to growth factors and replating potential (01a Articolo in rivista)
  • 11573/1221789 - 2012 - LINE-1 retrotransposon copies are amplified during murine early embryo development (01a Articolo in rivista)
    VITULLO, PATRIZIA
  • 11573/1221607 - 1988 - Selective extraction of haemagglutinin and matrix protein from Sendai virions by employing trifluoperazine as a detergent (01a Articolo in rivista)
  • 11573/1221618 - 1998 - Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope (01a Articolo in rivista)
  • 11573/114432 - 2010 - A novel high resolution, high sensitivity SPECT detector for molecular imaging of cardiovascular diseases (01a Articolo in rivista)
    DE VINCENTIS, GIUSEPPE; LUCENTINI, MARCO
  • 11573/1221902 - 2018 - How to assess drug resistance in cancer stem cells (02a Capitolo o Articolo)
  • 11573/1221915 - 1996 - Anti-HIV Viral Interference Induced by Retroviral Vectors Expressing a Nonproducer HIV-1 Variant (01a Articolo in rivista)
  • 11573/1221925 - 1994 - Stem cell factor and the amplification of progenitor cells from CD34+ cord blood cells (01a Articolo in rivista)
  • 11573/1221905 - 2003 - Myogenic potential of mouse primordial germ cells (01a Articolo in rivista)
    COLETTA, MARCELLO; COSSU, GIULIO
  • 11573/1221909 - 1993 - Simple purification and secondary structure evaluation of Sendai virus neuraminidase water soluble fragment (01a Articolo in rivista)
  • 11573/1336625 - 2019 - A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors (01a Articolo in rivista)
    FRANCESCANGELI, FEDERICA; FECCHI, KATIA; GIULIANI, ALESSANDRO; LA TORRE, FILIPPO
  • 11573/1494085 - 2020 - COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse? (01a Articolo in rivista)
  • 11573/1348337 - 2020 - A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer (01a Articolo in rivista)
    CIARDI, ANTONIO; D'ANDREA, VITO; LA TORRE, FILIPPO
  • 11573/1494081 - 2021 - Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 (01a Articolo in rivista)
    MATTIELLO, LEONARDO; PALLOCCA, MATTEO; SCALERA, SIMONA; PENNISI, ROSAMARIA; ANTONANGELI, FABRIZIO; BIFFONI, MARCO
  • 11573/1498763 - 2018 - In utero. La scienza e i nuovi modi di diventare madre (03a Saggio, Trattato Scientifico)
  • 11573/1336618 - 2019 - A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells (01a Articolo in rivista)
    FRANCESCANGELI, FEDERICA
  • 11573/365040 - 2007 - Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype (01a Articolo in rivista)
    CASTALDI, LAURA; SERRA, CARLO; MESSINA, GRAZIELLA; SAMPAOLESI, MAURILIO; PADULA, FABRIZIO; MOLINARO, MARIO; LEVRERO, MASSIMO; BOUCHE', MARINA
  • 11573/1221927 - 1993 - Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7 (01a Articolo in rivista)
    NICOLIS, SARA; OTTOLENGHI, SILVIA
  • 11573/1221911 - 1991 - Allosteric inhibition of the water-soluble C-terminal fragment of Sendai virus neuraminidase (01a Articolo in rivista)

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma